Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Bronchitol on Mucociliary Clearance in CFTR-Modulator Treated Cystic Fibrosis Patients
NCT05740618Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Mar 2023
- Primary completion
- Jan 2025
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Bronchitol in cystic fibrosis (CF), sponsored by University of North Carolina at Chapel Hill. Started Mar 2023; status: completed.
02
Drugs
Bronchitol
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT05740618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05740618.